| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-10 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |